Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion
PaperCitations, authors & open-access status
Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 449 citations, 2018 year and closed oa status.
449
Citations
2018
Year
closed
OA Status